Jacobs Levy Equity Management, Inc Akero Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $25.8 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$25.12 - $29.89 $1.42 Million - $1.69 Million
-56,533 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$30.79 - $39.92 $244,564 - $317,084
-7,943 Reduced 12.32%
56,533 $1.74 Million
Q2 2020

Aug 17, 2020
BUY
$19.25 - $26.76 $1.24 Million - $1.73 Million
64,476 New
64,476 $1.61 Million

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.22B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email